The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study
Open accessAbstract
BACKGROUND: In Gondar University Teaching Hospital standardized tuberculosis prevention and control programme, incorporating Directly Observed Treatment, Short Course (DOTS) started in 2000. According to the proposal of World Health Organization (WHO), treatment outcome is an important indicator of tuberculosis control programs. This study investigated the outcome of tuberculosis treatment at Gondar University Teaching Hospital in Northwest Ethiopia. METHODS: We analyzed the records of 4000 tuberculosis patients registered at Gondar University Teaching Hospital from September 2003 to May 2008. Treatment outcome and tuberculosis type were categorized according to the national tuberculosis control program guideline. Multivariate analysis using logistic regression model was used to analyse the association between treatment outcome and potential predictor variables. RESULTS: From the total of 4000 patients, tuberculosis type was categorized as extrapulmonary in 1133 (28.3%), smear negative pulmonary tuberculosis in 2196 (54.9%) and smear positive pulmonary tuberculosis in 671 (16.8%) cases. Of all patients, treatment outcome was classified as successfully treated in 1181(29.5%), defaulted in 730 (18.3%), died in 403 (10.1%), treatment failed in six (0.2%) and transferred out in 1680 (42.0%) patients. Males had the trend to be more likely to experience death or default than females, and the elderly were more likely to die than younger. The proportion of default rate was increased across the years from 97(9.2%) to 228(42.9%). Being female, age group 15-24 years, smear positive pulmonary tuberculosis and being urban resident were associated with higher treatment success rate. CONCLUSION: The treatment success rate of tuberculosis patients was unsatisfactorily low (29.5%). A high proportion of patients died (10.1%) or defaulted (18.3%), which is a serious public health concern that needs to be addressed urgently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, only a few studies have been conducted to assess the treatment outcome of TB patients in northern Ethiopia [7,9].”
From Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia (2014) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & FORESMAN, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 588
Global tuberculosis control: surveillance planning financing. WHO report 2008.
Dye, C., Floyd, K., & Uplekar, M. (2008) · Cited by 575
When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient Adherence
Sumartojo, E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1311 · Cited by 463
Siddiqi, K., Lambert, M., & Walley, J. D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00609-1 · Cited by 354
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Mukadi, Y. D., Maher, D., & Harries, A. D. (2001) · AIDS · doi:10.1097/00002030-200101260-00002 · Cited by 311
Chaulk, C. P. (1998) · JAMA · doi:10.1001/jama.279.12.943 · Cited by 272
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
Dye, C., Espinal, M., Watt, C. J., Mbiaga, C., & Williams, B. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339818 · Cited by 266
Research works printed but not linked: 10
- World Health Organisation (WHO): The world health report 2004: changing history. 2004, Geneva WHO
- Mukadi YD, Maher D, Harries A: Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001, 15: 143-152. 10.1097/00002030-200101260-00002. · DOI
- Chaulk CP, Kazandjian VA: Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the public health tuberculosis guidelines panel. JAMA. 1998, 279: 943-8. 10.1001/jama.279.12.943. · DOI
- Weis SE, Slocum PC, Blais FX: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994, 330: 1179-84. 10.1056/NEJM199404283301702. · DOI
- World Health Organization (WHO): Global Tuberculosis Control. WHO Report 2001. WHO/CDS/TB/2001. 2001, 287: 1-181.
- Harries AD, Nyong'Onya Mbewe L, Salaniponi FML: programme changes and treatment outcomes in patients with smear-positive tuberculosis in Blantyre, Malawi. Lancet. 1996, 347: 807-809. 10.1016/S0140-6736(96)90874-0. · DOI
- Klein NC, Duncanson FP, Lenox TH, Pitta A, Cohen SC, Wormser GP: Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest. 1989, 95: 1190-1192. 10.1378/chest.95.6.1190. · DOI
- Elliott AM, Namaambo K, Allen BW, Luo N, Hayes RJ, Pobee JO, McAdam KP: Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuberc Lung Dis. 1993, 74: 191-194. 10.1016/0962-8479(93)90010-U. · DOI
- Nunn P, Mungai M, Nyamwaya J, Gicheha C, Brindle RJ, Dunn DT, Githui W, Were JO, McAdam KP: The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis. 1994, 75: 25-32. 10.1016/0962-8479(94)90098-1. · DOI
- Siddiqi K, Lambert ML, Walley J: Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003, 3: 288-296. 10.1016/S1473-3099(03)00609-1. · DOI
Cited by
Sorted by citations
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 193
Berhe, G., Enquselassie, F., & Aseffa, A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-537 · Cited by 146
Tesfahuneygn, G., Medhin, G., & Legesse, M. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1452-x · Cited by 143
Gebrezgabiher, G., Romha, G., Ejeta, E., Asebe, G., Zemene, E., & Ameni, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150560 · Cited by 129
Getahun, B., Ameni, G., Medhin, G., & Biadgilign, S. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.12.010 · Cited by 100
Zeru, A. B., Tesfaw, G., Dejene, T., & Woldemichael, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144244 · Cited by 82
Kigozi, G., Heunis, C., Chikobvu, P., Botha, S., & van Rensburg, D. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.407 · Cited by 76
Eshetie, S., Gizachew, M., Alebel, A., & van Soolingen, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194675 · Cited by 73
Asres, A., Jerene, D., & Deressa, W. A. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0628-2 · Cited by 71
Treatment Outcomes of Tuberculosis and Associated Factors in an Ethiopian University Hospital
Gebeyehu, M. B., Yimam, B., Gesesew, H. A., Biruk, S., & Amdie, F. Z. (2016) · Advances in Public Health · doi:10.1155/2016/8504629 · Cited by 68
Endris, M., Moges, F., Belyhun, Y., Woldehana, E., Esmael, A., & Unakal, C. G. (2014) · Tuberculosis Research and Treatment · doi:10.1155/2014/726193 · Cited by 63
Treatment outcomes of childhood tuberculosis in Addis Ababa: a five-year retrospective analysis
Tilahun, G., & Gebre-Selassie, S. (2016) · BMC Public Health · doi:10.1186/s12889-016-3193-8 · Cited by 61
Ejeta, E., Beyene, G., Balay, G., Bonsa, Z., & Abebe, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205468 · Cited by 59
Maruza, M., de Albuquerque, M. D. F. P. M., Coimbra, I., Moura, L. V., Montarroyos, U. R., Miranda-Filho, D. B., Lacerda, H. R., Rodrigues, L. C., & Ximenes, R. A. A. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-351 · Cited by 57
Zenebe, T., & Tefera, E. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.07.012 · Cited by 50
Hamusse, S. D., Demissie, M., Teshome, D., & Lindtjørn, B. (2014) · Global Health Action · doi:10.3402/gha.v7.25382 · Cited by 52
Amante, T. D., & Abdosh, T. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.20.247.3345 · Cited by 46
Biadglegne, F., Anagaw, B., Debebe, T., Anagaw, B., Tesfaye, W., Tessema, B., Rodloff, A. C., & Sack, U. (2013) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms12.142 · Cited by 45
Self-citationGebremariam, G., Asmamaw, G., Hussen, M., Hailemariam, M., Fenta, D. A., Astatkie, A., & Amsalu, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153239 · Cited by 45
Kebede, W., Abebe, G., & Bonsa, Z. (2019) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_177_18 · Cited by 45
Djibuti, M., Mirvelashvili, E., Makharashvili, N., & Magee, M. J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-88 · Cited by 41
Ukwaja, K. N., Alobu, I., Ifebunandu, N. A., Osakwe, C., & Igwenyi, C. (2011) · Pan African Medical Journal · doi:10.4314/pamj.v9i1.71187 · Cited by 38
Worku, S., Derbie, A., Mekonnen, D. S., & Biadglegne, F. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0395-6 · Cited by 37
Melese, A., Zeleke, B., & Ewnete, B. (2016) · Tuberculosis Research and Treatment · doi:10.1155/2016/1354356 · Cited by 39
Factors associated with poor treatment outcome of tuberculosis in Debre Tabor, northwest Ethiopia
Melese, A., & Zeleke, B. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3129-8 · Cited by 37
Belayneh, M., Giday, K., & Lemma, H. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.09.002 · Cited by 36
Adamu, A. L., Aliyu, M. H., Galadanci, N. A., Musa, B. M., Lawan, U. M., Bashir, U., & Abubakar, I. I. (2018) · International Journal for Equity in Health · doi:10.1186/s12939-017-0714-8 · Cited by 36
Adane, K., Spigt, M., & Dinant, G. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0600-1 · Cited by 36
Ofoegbu, O. S., & Odume, B. B. (2015) · South African Family Practice · doi:10.1080/20786190.2014.995913 · Cited by 36
Seid, M. A., Ayalew, M. B., Muche, E. A., Gebreyohannes, E. A., & Abegaz, T. M. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022111 · Cited by 35
Hamdouni, M. E., Ahid, S., Bourkadi, J. E., Benamor, J., Hassar, M., & Cherrah, Y. (2019) · Infection · doi:10.1007/s15010-019-01324-3 · Cited by 35
Getie, ፟., & Alemnew, B. T. T. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s275568 · Cited by 35
Umoh, V. A., Otu, A., Okpa, H. O., & Effa, E. (2013) · Pulmonary Medicine · doi:10.1155/2013/581973 · Cited by 34
Zenebe, Y., Anagaw, B., Tesfay, W., Debebe, T., & Gelaw, B. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-21 · Cited by 33
Wubie, M. G. B. M. T. (2013) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000101 · Cited by 33
Tarekegne, D., Jemal, M., Atanaw, T., Ebabu, A., Endris, M., Moges, F., Tessema, B., & Deressa, T. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2004-8 · Cited by 33
Self-citationZenebe, Y., Adem, Y., Mekonnen, D. S., Derbie, A., Bereded, F., Bantie, M., Tulu, B., Hailu, D., & Biadglegne, F. (2016) · BMC Public Health · doi:10.1186/s12889-016-3362-9 · Cited by 33
Wondale, B., Medhin, G., Teklu, T., Mersha, W., Tamirat, M., & Ameni, G. (2017) · BMC Research Notes · doi:10.1186/s13104-017-3020-z · Cited by 33
Gebreegziabher, S. B., Yimer, S. A., & Bjune, G. A. (2016) · Journal of Tuberculosis Research · doi:10.4236/jtr.2016.41004 · Cited by 32
Outcome of Tuberculosis patients under directly observed short course treatment in western Ethiopia
Ejeta, E., Chala, M., Berihun, G. A., Ayalsew, K., Tesfaye, L., Birhanu, T., & Disassa, H. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.5963 · Cited by 30
Fekadu, G., Turi, E., Kasu, T., Bekele, F., Chelkeba, L., Tolossa, T., Labata, B. G., Dugassa, D., Fetensa, G., & Diriba, D. C. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.11.032 · Cited by 30
Tafess, K., Beyen, T. K., Abera, A., Tasew, G., Mekit, S., Sisay, S., Tadesse, L., & Siu, G. G. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00038 · Cited by 28
Survival analysis of patients with tuberculosis in Erbil, Iraqi Kurdistan region
Balaky, S. T. J., Mawlood, A. H., & Shabila, N. P. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4544-8 · Cited by 27
Hayibor, K. M., Bandoh, D. A., Asante-Poku, A., & Kenu, E. (2020) · Tuberculosis Research and Treatment · doi:10.1155/2020/1097581 · Cited by 27
Melaku, S., Sharma, H. R., & Alemie, G. A. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/475605 · Cited by 27
Duru, C. B., Uwakwe, K., Nnebue, C. C., Diwe, K. C., Merenu, I. A., Emerole, C. A., Iwu, A. C., & Duru, C. A. (2016) · OALib · doi:10.4236/oalib.1102754 · Cited by 26
Laghari, M., Sulaiman, S. A. S., Khan, A. H., & Memon, N. (2018) · PeerJ · doi:10.7717/peerj.5253 · Cited by 26
Temesgen, M. M., Mariam, S. H., Airgecho, T., Belachew, E. G., & Aseffa, A. (2015) · Tuberculosis Research and Treatment · doi:10.1155/2015/215015 · Cited by 25
Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan
Yen, Y., Yen, M., Shih, H.-C., & Deng, C.-Y. (2012) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2012.01.011 · Cited by 25
Asres, A., Jerene, D., & Deressa, W. A. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1917-0 · Cited by 25
Asebe, G., & Disassa, H. (2015) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000211 · Cited by 24
El-Shabrawy, M., & El-Shafei, D. A. (2016) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2015.11.002 · Cited by 23
Mekonnen, D. S., Derbie, A., Mekonnen, H., & Zenebe, Y. (2016) · African Health Sciences · doi:10.4314/ahs.v16i3.4 · Cited by 23
Legesse, T., Admenur, G., Gebregzabher, S., Woldegebriel, E., Fantahun, B., Tsegay, Y., Bayssa, A., Darge, B., Denbu, Y., Michalel, H., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05828-y · Cited by 23
Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia
Tadesse, S., & Tadesse, T. (2014) · Health · doi:10.4236/health.2014.65044 · Cited by 22
“The area is typical of the rural population of Ethiopia, representing 85.0% of the total population, where the prevalence of TB is high because of limited health service coverage, shortage of health workers, inadequate diagnostic and treatment facilities, and high social and perceived stigma [18].”
BackgroundInfluentialHIV co-infection among tuberculosis patients in Dabat, northwest Ethiopia
Tadesse, S. (2013) · Journal of Infectious Diseases and Immunity · doi:10.5897/jidi2013.0117 · Cited by 21
Getnet, F., Sileshi, H., Seifu, W., Yirga, S., & Alemu, A. S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2882-y · Cited by 21
Time to death and risk factors among tuberculosis patients in Northern Ethiopia
Asgedom, S. W., Tesfaye, D., Nirayo, Y. L., & Atey, T. M. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3806-7 · Cited by 20
Fentie, A. M., Jorgi, T., & Tadesse, T. A. (2020) · Archives of Public Health · doi:10.1186/s13690-020-0393-6 · Cited by 19
Treatment Outcome of Tuberculosis Patients in Azezo Health Center, North West Ethiopia
Addis, Z., Birhan, W., Alemu, A., Mulu, A., Ayal, G., & Negash, H. (2013) · International Journal of Biomedical and Advance Research · doi:10.7439/ijbar.v4i3.300 · Cited by 19
Ahmad, T., Haroon, H., Khan, M. M., Khan, M., Ejeta, E., Karami, M., & Ohia, C. (2017) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_69_17 · Cited by 18
Abdulkader, M., van Aken, I., Niguse, S., Hailekiros, H., & Spigt, M. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4824-9 · Cited by 18
Yen, Y.-F., Rodwell, T. C., Yen, M.-Y., Shih, H.-C., Hu, B.-S., Li, L.-H., Shie, Y.-H., Chuang, P., & Garfein, R. S. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0034 · Cited by 18
Aung, Y. K., Swe, P. P., Kyaw, Z., & Thein, S. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218450 · Cited by 17
Tarekegne, M. J. D. (2014) · Mycobacterial Diseases · doi:10.4172/2161-1068.1000190 · Cited by 16
Mortality among tuberculosis patients under DOTS programme: a historical cohort study
Beyene, Y., Kibret, B. G., & Baye, A. M. (2016) · BMC Public Health · doi:10.1186/s12889-016-3557-0 · Cited by 16
Gabida, M., Tshimanga, M., Chemhuru, M., Gombe, N. T., & Bangure, D. (2015) · Journal of Tuberculosis Research · doi:10.4236/jtr.2015.34019 · Cited by 16
Factors affecting compliance to tuberculosis treatment in Andara Kavango region Namibia
Chani, K. (2010) · Unisa Institutional Repository (University of South Africa) · Cited by 15
Zenbaba, D., Debela, M. B., & Sahiledengle, B. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07982 · Cited by 14
Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China.
Wang, N., Ma, Y., Liu, Y. H., Du, J., Zhang, H., Xie, S. H., Zhu, K., Lyu, X. Y., Shu, W., Wang, H. H., et al. (2016) · PubMed · doi:10.3967/bes2016.083 · Cited by 14
Sintayehu, W. (2014) · International Journal of Immunology · doi:10.11648/j.iji.20140202.11 · Cited by 13
Tefera, F., Dejene, T., & Tewelde, T. (2016) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v26i1.11 · Cited by 13
Documentation and treatment outcomes of smear-negative and extra-pulmonary tuberculosis in Ethiopia
Tesgaye, F., Defar, A., Beyene, T., Shafi, O., Klinkenberg, E., & Howe, R. (2014) · Public Health Action · doi:10.5588/pha.14.0052 · Cited by 13
Belayneh, T., Kassu, A., Tigabu, D., Asmare, G., Tilaye, S., & Klinkenberg, E. (2016) · Tuberculosis Research and Treatment · doi:10.1155/2016/1294876 · Cited by 13
Yen, Y., Yen, M.-Y., Lin, Y.-P., Shih, H.-C., Li, L.-H., Chou, P., & Deng, C.-Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079644 · Cited by 13
Eyasu, E., Tadesse, B., & Wolde, T. (2014) · Journal of AIDS and HIV Research · doi:10.5897/jahr2014.0312 · Cited by 13
Factors Affecting Treatment Outcome of Tuberculosis among Tuberculosis Patients in West Ethiopia
Kassa, J. I., Dedefo, M. G., Korsa, A. T., & Dibessa, T. T. (2018) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000200 · Cited by 12
Ten Years Tuberculosis Trend in Gambella Regional Hospital, South Western Ethiopia
Asebe, G., Ameni, G., & Tafess, K. (2014) · Malaysian Journal of Medical and Biological Research · doi:10.15590/mjmbr/2014/v1i1/53716 · Cited by 11
Rahimi, B. A., Rahimy, N., Mukaka, M., Ahmadi, Q., Hayat, M. S., & Wasiq, A. W. (2019) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_142_19 · Cited by 11
Weldegebreal, F., Mitiku, H., & Teklemariam, Z. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.30.32.12554 · Cited by 10
Kebede, W., Gudina, E. K., Balay, G., & Abebe, G. (2021) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2021.100220 · Cited by 10
Woldesemayat, E. M., & Azeze, Z. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249369 · Cited by 9
Shibabaw, A. M. A., & Belay, E. H. M. (2015) · Journal of Bacteriology & Parasitology · doi:10.4172/2155-9597.1000240 · Cited by 10
Reviewing treatment outcomes of tuberculosis patients at Zagazig Chest Hospital (2008–2012)
Nafae, R. M., El-Shahat, H., Said, A. M., & Ibrahim, M. A.-H. (2017) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2017.10.006 · Cited by 8
Perforated tuberculous appendicitis: a rare case report
Mekonnen, A. G., & Bekele, K. (2018) · International Medical Case Reports Journal · doi:10.2147/imcrj.s158074 · Cited by 8
Alelign, A., Petros, B., & Ameni, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216437 · Cited by 8
(2024) · Jurnal Epidemiologi Kesehatan Indonesia · doi:10.7454/epidkes.v8i1.1100 · Cited by 7
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan
Rahimi, B. A., Rahimy, N., Ahmadi, Q., Hayat, M. S., & Wasiq, A. W. (2018) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2018.10.008 · Cited by 7
Tuberculosis Lymphadenitis in Northwest Ethiopia: Implications for Public Health
Biadglegne, F., Anagaw, B., Anagaw, B., Tesfaye, W., Tessema, B., Sack, U., & Rodloff, A. C. (2013) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2013.31004 · Cited by 6
Self-citationMULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS IN ADAMAWA STATE, NIGERIA.
Omisore, N. O., Oyewole, M. O., & Akinkunmi, E. O. (2019) · Europe PMC (PubMed Central) · doi:10.21010/ajid.v13i1.5 · Cited by 6
Ramos, J. M., Tesfamariam, A., Balcha, S., Biru, D., Reyes, F., & Górgolas, M. (2013) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2013.02.001 · Cited by 5
Ayele, B., & Nenko, G. (2015) · Mycobacterial Diseases · doi:10.4172/2161-1068.1000194 · Cited by 5
Jabir, Y. N., Aniley, T. T., Bacha, R. H., Debusho, L. K., Chikako, T. U., Hagan, J. E., Seidu, A., & Ahinkorah, B. O. (2022) · Diseases · doi:10.3390/diseases10030051 · Cited by 5
Alem, Y., & Gebre-Selassie, S. (2017) · Journal of Lung Health and Diseases · doi:10.29245/2689-999x/2017/1.1106 · Cited by 5
Evaluation of a Tuberculosis Surveillance System in the Harare City Health Department in Zimbabwe
Matambo, R., Duri, C., Ruhanya, V., Mungofa, S., Chadambuka, E. M., Nyandoro, G., Mugomeri, E., & Chin’ombe, N. (2016) · International Journal of TROPICAL DISEASE & Health · doi:10.9734/ijtdh/2016/24056 · Cited by 4
Mekonnen, D. S., Nibret, E., Munshea, A., Derbie, A., Zenebe, Y., Tadese, A., Birku, T., Tesfa, E., Sinishaw, M. A., Getachew, H., et al. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01821-3 · Cited by 4
Teka, D., Assegid, S., Ahmed, J., Debella, A., Amentie, E., Wami, G. A., & Eyeberu, A. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s428652 · Cited by 4
Teklesilassie, S., Gelana, T., & Alelign, T. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11725-5 · Cited by 3
Surveillance of HIV Infection among Patients with Tuberculosis in Nepal
Sah, S. K., Verma, S. C., Bhattarai, R., Bhandari, K., & Bhatta, G. K. (2016) · SAARC Journal of Tuberculosis Lung Diseases and HIV/AIDS · doi:10.3126/saarctb.v12i1.15939 · Cited by 3
Prevalence of tuberculosis in Ethiopia: an umbrella review of systematic review and meta-analysis
Abebe, W., Gedfie, S., & Emagneneh, T. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1555901 · Cited by 3
Metadata
- Authors
- Tessema, B., Muche, A., Bekele, A., Reissig, D., Emmrich, F., & Sack, U.
- Affiliations
- University of Gondar (ET)
- Leipzig University (DE)
- Fraunhofer Institute for Cell Therapy and Immunology (DE)
- Corresponding author
- Tessema, Belay
- Venue
- BMC Public Health
- Published
- 2009-10-04
- Volume
- 9
- Issue
- 1
- Pages
- 371-371
- ISSN
- 1471-2458 (ISSN-L)
- PMC
- PMC2765962
- OpenAlex
- W2059980350
- Cited by
- 154
- References
- 32
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 15 · 2018: 26 · 2017: 10 · 2016: 22 · 2015: 13 · 2014: 16 · 2013: 13 · 2012: 3
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- tuberculosis, treatment outcomes, DOTS, treatment default, tuberculosis mortality, smear-negative tuberculosis, extrapulmonary tuberculosis, sex differences, age differences, urban residence, predictors of treatment success
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Child, Child, Preschool, Ethiopia, Hospitals, Teaching, Humans, Infant, Middle Aged, Patient Compliance, Retrospective Studies, Tuberculosis, Treatment Outcome, Treatment Failure, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review